£228 M

VRP.L Mkt cap, 29-Oct-2020
Verona Pharma Net income (FY, 2018)-19.9 M
Verona Pharma EBITDA (FY, 2018)-25.6 M
Verona Pharma EBIT (FY, 2018)-25.6 M
Verona Pharma Cash, 31-Dec-201819.8 M

Verona Pharma Income Statement

Annual

GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

EBITDA

(1.3m)(1.5m)(1.6m)(1.9m)(1.8m)(2.6m)(2.8m)(3.7m)(8.9m)(6.9m)(29.7m)(25.6m)

EBIT

11.4k671.1k(1.3m)(1.5m)(1.6m)(1.9m)(1.8m)(2.6m)(2.8m)(3.8m)(9.0m)(7.0m)(29.8m)(25.6m)

Pre tax profit

26.0k(608.4k)(1.2m)(1.3m)(1.6m)(1.9m)(1.8m)(2.6m)(2.8m)(3.8m)(9.0m)(6.0m)(25.2m)(24.1m)

Income tax expense

(27.9k)(4.5k)124.4k48.1k289.4k1.0m1.5m954.0k4.7m4.2m

Net Income

26.0k(608.4k)(1.2m)(1.4m)(1.6m)(1.9m)(1.7m)(2.5m)(2.5m)(2.8m)(7.5m)(5.0m)(20.5m)(19.9m)

Verona Pharma Balance Sheet

Annual

GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

982.4k1.1m1.3m2.5m2.8m2.0m2.5m960.9k603.8k10.0m3.5m39.8m31.4m19.8m

Current Assets

991.3k2.4m1.5m2.5m3.2m2.1m2.6m1.2m853.4k11.3m5.6m43.8m87.1m71.7m

PP&E

17.4k16.1k14.1k18.0k15.5k6.0k39.5k27.6k21.8k13.2k14.0k16.0k21.0k

Goodwill

1.8m2.3m2.3m

Total Assets

991.3k4.0m3.0m4.1m4.8m3.7m4.2m2.8m2.6m13.1m7.8m46.1m89.5m74.3m

Accounts Payable

33.6k98.2k48.7k117.4k141.6k89.0k135.6k329.8k366.6k1.1m719.0k1.2m2.8m

Current Liabilities

11.7k65.9k157.3k84.2k286.9k206.3k156.0k199.3k489.3k524.3k1.8m10.9m8.6m10.2m

Non-Current Liabilities

593.9k802.0k1.0m1.1m

Total Liabilities

11.7k65.9k157.3k84.2k286.9k206.3k156.0k199.3k489.3k524.3k2.4m11.7m9.6m11.3m

Common Stock

50.2k144.3k146.8k215.3k232.4k239.9k285.8k307.2k372.6k1.0m1.0m2.6m5.3m5.3m

Retained Earnings

(13.1m)(15.7m)(23.8m)(28.7m)(49.3m)(69.1m)

Total Equity

979.6k3.9m2.9m4.0m4.5m3.5m4.1m2.6m2.1m12.6m5.4m34.5m79.9m62.9m

Financial Leverage

1 x1 x1.1 x1 x1.1 x1.1 x1 x1.1 x1.2 x1 x1.4 x1.3 x1.1 x1.2 x

Verona Pharma Cash Flow

Annual

GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

26.0k(608.4k)(1.2m)(1.4m)(1.6m)(1.9m)(1.7m)(2.5m)(2.5m)(2.8m)(7.5m)(5.0m)(20.5m)(19.9m)

Cash From Operating Activities

351.3k1.2m(1.3m)(1.6m)(1.7m)(1.7m)(2.6m)(2.3m)(3.5m)(6.4m)(5.6m)(20.7m)(18.1m)

Cash From Financing Activities

1.7m2.4m2.0m873.9k2.1m1.0m1.8m13.1m41.2m63.2m

Net Change in Cash

80.8k188.8k1.2m375.1k(827.0k)523.2k(1.6m)(357.1k)9.4m(6.4m)35.6m(6.9m)(12.8m)

Income Taxes Paid

1.0m1.5m954.2k

Verona Pharma Ratios

GBPFY, 2005

Financial Leverage

1 x